Publication Title ("American Heart Journal") And Id (0897) And Date (Apr 01, 2023) And Volume Number (258) - Results

Pursuing functional biomarkers in complex disease: Focus on pulmonary arterial hypertension.

Authors:Giuditta Benincasa, Claudio Napoli, Joseph Loscalzo, and Bradley A. MaronFrom:American Heart Journal (Vol. 258) Peer-Reviewed

Apr. 2023461 words Report

Abstract Only

[beta]eta blocker interruption after uncomplicated myocardial infarction: rationale and design of the randomized ABYSS trial.

Authors:Johanne Silvain, Guillaume Cayla, Emile Ferrari, Grégoire Range, Etienne Puymirat, Nicolas Delarche, et al.From:American Heart Journal (Vol. 258) Peer-Reviewed

Apr. 2023605 words Article

Abstract Only

Design and pilot implementation for the BETTER CARE-HF trial: A pragmatic cluster-randomized controlled trial comparing two targeted approaches to ambulatory clinical decision support for cardiologists.

Authors:Amrita Mukhopadhyay, Harmony R. Reynolds, Yuhe Xia, Lawrence M. Phillips, Rod Aminian, Ruth-Ann Diah, et al.From:American Heart Journal (Vol. 258) Peer-Reviewed

Apr. 2023471 words Article

Abstract Only

Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor.

Authors:Matthew Johnson, Fritha J. Morrison, Gearoid McMahon, Maxwell Su, and Alexander TurchinFrom:American Heart Journal (Vol. 258) Peer-Reviewed

Apr. 2023383 words Brief article

Abstract Only

Association of ACEI/ARB and statin prescribing patterns with mortality after Transcatheter Aortic Valve Replacement (TAVR): Findings from real-world claims data.

Authors:Robert J. Cubeddu, Shannon M.E. Murphy, Craig R. Asher, Santiago A. Garcia, Juan F. Granada, Creighton W. Don, et al.From:American Heart Journal (Vol. 258) Peer-Reviewed

Apr. 2023509 words Report

Abstract Only

Feasibility and outcomes from using a commitment device and text message reminders to increase adherence to time-restricted eating: A randomized trial.

Authors:Alexander C. Fanaroff, Samantha Coratti, Rim Halaby, Monika Sanghavi, Rupal P. O'Quinn, Sheela Krishnan, et al.From:American Heart Journal (Vol. 258) Peer-Reviewed

Apr. 2023659 words Report

Abstract Only

Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy.

Authors:Guangguo Fu, Zhuoming Zhou, Bohao Jian, Suiqing Huang, Zicong Feng, Mengya Liang, et al.From:American Heart Journal (Vol. 258) Peer-Reviewed

Apr. 2023412 words Article

Abstract Only

Evaluation of the association between circulating IL-1[beta] and other inflammatory cytokines and incident atrial fibrillation in a cohort of postmenopausal women.

Authors:Sofia E. Gomez, Justin Parizo, Simon Ermakov, Joseph Larson, Robert Wallace, Themistocles Assimes, et al.From:American Heart Journal (Vol. 258) Peer-Reviewed

Apr. 2023350 words Report, Brief articl...

Abstract Only

Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial.

Authors:Christian Spaulding, Florian Krackhardt, Kris Bogaerts, Philip Urban, Susanne Meis, Marie-Claude Morice, et al.From:American Heart Journal (Vol. 258) Peer-Reviewed

Apr. 2023541 words Article

Abstract Only

Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making.

Authors:Raquel López-Galvez, José Miguel Rivera-Caravaca, Vanessa Roldán, Esteban Orenes-Piñero, María Asunción Esteve-Pastor, Cecilia López-García, et al.From:American Heart Journal (Vol. 258) Peer-Reviewed

Apr. 2023546 words Report

Abstract Only

Characteristics and outcomes of patients with no standard modifiable risk factors undergoing primary revascularization for acute myocardial infarction: Insights from the nationwide Japanese percutaneous coronary intervention registry.

Authors:Yuichi Saito, Taku Inohara, Shun Kohsaka, Hideki Wada, Itaru Takamisawa, Kyohei Yamaji, et al.From:American Heart Journal (Vol. 258) Peer-Reviewed

Apr. 2023406 words Report

Abstract Only

Prehospital treatment with zalunfiban (RUC-4) in patients with ST- elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial.

Authors:Sem A.O.F. Rikken, Abi Selvarajah, Renicus S. Hermanides, Barry S. Coller, C. Michael Gibson, Christopher B. Granger, et al.From:American Heart Journal (Vol. 258) Peer-Reviewed

Apr. 2023646 words Report

Abstract Only

Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarction.

Authors:Ronak Delewi, Rosanne F. Vogel, Jeroen M. Wilschut, Miguel E. Lemmert, Roberto Diletti, Ria van Vliet, et al.From:American Heart Journal (Vol. 258) Peer-Reviewed

Apr. 2023515 words Article

Abstract Only

Mortality and rehospitalization after mitral valve surgery as a function of age and key comorbidities.

Authors:Eva Havers-Borgersen, Jawad H. Butt, Jarl Strange, Christian L. Carranza, Lars Køber, and Emil L. FosbølFrom:American Heart Journal (Vol. 258) Peer-Reviewed

Apr. 2023433 words Article

Abstract Only

Trends in outcomes and resource utilization for acute myocardial infarction admissions during the COVID-19 pandemic.

Authors:Fouad Chouairi, Bret Pinsker, Marat Fudim, and P. Elliott MillerFrom:American Heart Journal (Vol. 258) Peer-Reviewed

Apr. 2023209 words Brief article

Abstract Only

Public reporting of black participation in anti-hypertensive drug clinical trials.

Authors:Michael D. Green, Mahalia R. Dalmage, Jay B. Lusk, Emilie F. Kadhim, Lesley A. Skalla, and Emily C. O'BrienFrom:American Heart Journal (Vol. 258) Peer-Reviewed

Apr. 2023422 words Article

Abstract Only

Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial.

Authors:Kelley R.H. Branch, Jeffrey L. Probstfield, Jackie Bosch, Deepak L. Bhatt, Aldo P. Maggioni, Eva Muehlhofer, et al.From:American Heart Journal (Vol. 258) Peer-Reviewed

Apr. 2023490 words Report

Abstract Only

Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry.

Authors:Ankeet S. Bhatt, Lori B. Daniels, James de Lemos, Erica Goodrich, Erin A. Bohula, and David A. MorrowFrom:American Heart Journal (Vol. 258) Peer-Reviewed

Apr. 2023440 words Report

Abstract Only

Open Access User

Library Information

Showing Results for

Search Results

Academic Journals

Pursuing functional biomarkers in complex disease: Focus on pulmonary arterial hypertension.

[beta]eta blocker interruption after uncomplicated myocardial infarction: rationale and design of the randomized ABYSS trial.

Design and pilot implementation for the BETTER CARE-HF trial: A pragmatic cluster-randomized controlled trial comparing two targeted approaches to ambulatory clinical decision support for cardiologists.

Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor.

Association of ACEI/ARB and statin prescribing patterns with mortality after Transcatheter Aortic Valve Replacement (TAVR): Findings from real-world claims data.

Feasibility and outcomes from using a commitment device and text message reminders to increase adherence to time-restricted eating: A randomized trial.

Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy.

Evaluation of the association between circulating IL-1[beta] and other inflammatory cytokines and incident atrial fibrillation in a cohort of postmenopausal women.

Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial.

Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making.

Characteristics and outcomes of patients with no standard modifiable risk factors undergoing primary revascularization for acute myocardial infarction: Insights from the nationwide Japanese percutaneous coronary intervention registry.

Prehospital treatment with zalunfiban (RUC-4) in patients with ST- elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial.

Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarction.

Mortality and rehospitalization after mitral valve surgery as a function of age and key comorbidities.

Trends in outcomes and resource utilization for acute myocardial infarction admissions during the COVID-19 pandemic.

Public reporting of black participation in anti-hypertensive drug clinical trials.

Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial.

Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry.

Filter Your Results